Deutsch English Français

Contact

EP2922872

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP2922872

EP2922872 - BISPECIFIC EGFR/C-MET ANTIBODIES [Right-click to bookmark this link]
Former [2015/40]	BISPECIFIC EGFR/c-Met ANTIBODIES
	[2018/16]
Status	No opposition filed within time limit Status updated on 16.08.2019 Database last updated on 24.04.2024
Former	The patent has been granted Status updated on 07.09.2018
Former	Grant of patent is intended Status updated on 18.04.2018
Former	Examination is in progress Status updated on 21.07.2017
Former	Request for examination was made Status updated on 08.02.2017
Most recent event Tooltip	07.07.2023	Change - lapse in a contracting state State(s) deleted from list of lapses: SM	published on 09.08.2023 [2023/32]
Applicant(s)	For all designated states Janssen Biotech, Inc. 800/850 Ridgeview Drive Horsham, PA 19044 / US
	[2015/40]
Inventor(s)	01 / CHIU, Mark 1400 McKean Road Spring House Pennsylvania 19477 / US
	02 / MOORES, Sheri 1400 McKean Road Spring House Pennsylvania 19477 / US
	03 / NEIJSSEN, Joost Yalelaan 60 3854 Ultrecht / NL
	04 / PARREN, Paul Yalelaan 60 3854 Ultrecht / NL
	05 / SCHUURMAN, Janine Yalelaan 60 3854 Ultrecht / NL
	[2018/20]
Former [2015/40]	01 / CHIU, Mark 1400 McKean Road Spring House Pennsylvania 19477 / US
	02 / MOORES, Sheri 1400 McKean Road Spring House Pennsylvania 19477 / US
	03 / NEIJSSEN, Joost Yalelaan 60 NL-3854 Ultrecht / NL
	04 / PARREN, Paul Yalelaan 60 NL-3854 Ultrecht / NL
	05 / SCHUURMAN, Janine Yalelaan 60 NL-3854 Ultrecht / NL
Representative(s)	Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
	[2015/40]
Application number, filing date	13856592.4	21.11.2013
	[2015/40]
	WO2013US71288
Priority number, date	US201261728912P	21.11.2012 Original published format: US 201261728912 P
	US201361782550P	14.03.2013 Original published format: US 201361782550 P
	US201361809541P	08.04.2013 Original published format: US 201361809541 P
	US201361864717P	12.08.2013 Original published format: US 201361864717 P
	US201361892797P	18.10.2013 Original published format: US 201361892797 P
	[2015/40]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2014081954
	Date:	30.05.2014
	Language:	EN
	[2014/22]
	Type:	A1 Application with search report
	No.:	EP2922872
	Date:	30.09.2015
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 30.05.2014 takes the place of the publication of the European patent application.
	[2015/40]
	Type:	B1 Patent specification
	No.:	EP2922872
	Date:	10.10.2018
	Language:	EN
	[2018/41]
Search report(s)	International search report - published on:	US	30.05.2014
	(Supplementary) European search report - dispatched on:	EP	02.06.2016
Classification	IPC:	C07K16/00, A61K39/395, A61K31/4545, A61K31/517, A61K45/06, A61K31/437, A61K31/5377, A61K33/24, C07K16/28, A61P35/00	[2016/27]
	CPC:	C07K16/2863 (EP,EA,KR,US); A61K31/437 (EP,US); A61K31/4545 (EP,US); A61K31/517 (EP,US); A61K31/5377 (EP,US); A61K33/243 (EP,EA,US); (+) A61K39/395 (EP,EA,US); A61K39/3955 (EA,US); A61K45/06 (EP,US); A61P35/00 (EP,EA,KR); A61P35/04 (EP); A61P43/00 (EP); C12N15/63 (EA); A61K2039/505 (EP,KR,US); C07K2317/31 (EP,KR,US); C07K2317/73 (EP,KR,US); C07K2317/76 (EP,KR,US); C07K2318/20 (EP,US) (-)
	C-Set:	A61K31/4545, A61K2300/00 (US,EP); A61K31/517, A61K2300/00 (US,EP); A61K39/395, A61K2300/00 (EP,US)
	Former IPC [2015/40]	C07K16/00
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/40]
Extension states	BA	22.06.2015
	ME	22.06.2015
Title	German:	BISPEZIFISCHE EGFR/C-MET-ANTIKÖRPER	[2015/40]
	English:	BISPECIFIC EGFR/C-MET ANTIBODIES	[2018/16]
	French:	ANTICORPS EGFR/C-MET BISPÉCIFIQUES	[2015/40]
	Former [2015/40]	BISPECIFIC EGFR/c-Met ANTIBODIES
Entry into regional phase	22.06.2015	National basic fee paid
	22.06.2015	Search fee paid
	22.06.2015	Designation fee(s) paid
	22.06.2015	Examination fee paid
Examination procedure	22.06.2015	Examination requested [2015/40]
	09.02.2017	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
	11.04.2017	Amendment by applicant (claims and/or description)
	25.07.2017	Despatch of a communication from the examining division (Time limit: M04)
	27.11.2017	Reply to a communication from the examining division
	19.04.2018	Communication of intention to grant the patent
	29.08.2018	Fee for grant paid
	29.08.2018	Fee for publishing/printing paid
	29.08.2018	Receipt of the translation of the claim(s)
Divisional application(s)	EP18199421.1 / EP3447069
	EP20197551.3 / EP3808767
	EP23214289.3
	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 25.07.2017
Opposition(s)	11.07.2019	No opposition filed within time limit [2019/38]
Request for further processing for:	The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
	11.04.2017	Request for further processing filed
	11.04.2017	Full payment received (date of receipt of payment) Request granted
	12.05.2017	Decision despatched
Fees paid	Renewal fee
	10.11.2015	Renewal fee patent year 03
	10.11.2016	Renewal fee patent year 04
	13.11.2017	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	deleted
	[2023/32]
Former [2019/37]	SM	12.06.2019
Documents cited:	Search	[Y]WO02100348 (GENMAB AS [DK], et al) [Y] 1-15 * the whole document *;
		[Y]WO2004056847 (GENMAB AS [DK], et al) [Y] 1-15 * claims 1, 3; sequences 2, 4 *;
		[Y]WO2011110642 (GENMAB AS [DK], et al) [Y] 1-15 * the whole document * * sequences 141, 143, 101 *;
		[Y]WO2011131746 (GENMAB AS [DK], et al) [Y] 1-15 * the whole document *;
		[Y]WO2012042026 (ABLYNX NV [BE], et al) [Y] 1-15 * the whole document * * examples 13-15 *;
		[T]WO2014081944 (JANSSEN BIOTECH INC [US]) [T] 1-15;
		[XP] - CHRISTOPH SPIESS ET AL, "Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies", NATURE BIOTECHNOLOGY, (20130707), vol. 31, no. 8, doi:10.1038/nbt.2621, ISSN 1087-0156, pages 753 - 758, XP055127867 [XP] 1-15 * the whole document * DOI: http://dx.doi.org/10.1038/nbt.2621
	International search	[A]US2005118643 (BURGESS TERESA L [US], et al);
		[X]US2010254989 (BOSSENMAIER BIRGIT [DE], et al);
		[A]US2011091372 (GHAYUR TARIQ [US], et al);
		[A]US2011097262 (GOETSCH LILIANE [FR], et al)
	Examination	WO2013055404
	by applicant	US4683195
		WO8801649
		WO9201047
		US5212290
		US5223409
		WO9413804
		US5403484
		US5427908
		US5558864
		US5571698
		US5580717
		US5643768
		WO9844001
		US5856456
		US5885793
		US5891996
		US5969108
		US6172197
		US6472147
		WO02100348
		US6521404
		US6544731
		US6555313
		US6582915
		US6593081
		US6673901
		US6737056
		WO2004056847
		US2004166544
		US2004197332
		WO2005016382
		US6969108
		US2005272083
		WO2006015371
		WO2006028936
		US7247301
		WO2008077546
		WO2008127710
		US2009042906
		WO2009030239
		US2009118127
		WO2009085462
		US2009182127
		WO2009111691
		US7589180
		US7595378
		WO2009126834
		US2010015133
		US2010028637
		WO2010039248
		US2010216708
		US2010254989
		WO2010115551
		US7842476
		US2011118144
		US2011123532
		WO2011066501
		WO2011110642
		US2011256142
		WO2011131746
		US2011274623
		WO2012042026
		US2012149876
		US2013195849
	US2013226834
	- FERGUSON et al., Annu Rev Biophys, (20080000), vol. 37, pages 353 - 73
	- MENDELSOHN et al., Oncogene, (20000000), vol. 19, pages 6550 - 6565
	- GRUNWALD et al., J Natl Cancer Inst, (20030000), vol. 95, pages 851 - 67
	- MENDELSOHN et al., Semin Oncol, (20060000), vol. 33, pages 369 - 85
	- HIRSCH et al., Ann Oncol, (20070000), vol. 18, pages 752 - 60
	- BASELGA; ARTEAGA, J Clin Oncol, (20050000), vol. 23, pages 2445 - 2459
	- GILL et al., J Biol Chem, (19840000), vol. 259, pages 7755 - 7760
	- GOLDSTEIN et al., Clin Cancer Res, (19950000), vol. 1, pages 131 1 - 1318
	- PREWETT et al., Clin Cancer Res, (19980000), vol. 4, pages 2957 - 2966
	- DE ROOCK et al., Lancet Oncol, (20100000), vol. 11, pages 753 - 762
	- LINARDOU et al., Nat Rev Clin Oncol, (20090000), vol. 6, pages 352 - 366
	- LI; PEREZ-SOLER, Targ Oncol, (20090000), vol. 4, pages 107 - 119
	- RIELY et al., Clin Cancer Res, (20060000), vol. 12, pages 839 - 44
	- COOPER et al., Nature, (19840000), vol. 311, pages 29 - 33
	- CHRISTENSEN et al., Cancer Lett, (20050000), vol. 225, pages 1 - 26
	- PETERS; ADJEI, Nat Rev Clin Oncol, (20120000), vol. 9, pages 314 - 26
	- MA et al., Cancer and Metastasis Reviews, (20030000), vol. 22, pages 309 - 325
	- STAMOS et al., The EMBO Journal, (20040000), vol. 23, pages 2325 - 2335
	- SCHMIDT et al., Oncogene, (19990000), vol. 18, pages 2343 - 2350
	- SAKAKURA et al., Chromosomes and Cancer, (19990000), vol. 24, pages 299 - 305
	- SIERRA; TSAO, Therapeutic Advances in Medical Oncology, (20110000), vol. 3, pages 21 - 35
	- ICHIMURA et al., Jpn J Cancer Res, (19960000), vol. 87, pages 1063 - 9
	- SIEGFRIED et al., Ann Thorac Surg, (19980000), vol. 66, pages 1915 - 8
	- TURKE et al., Cancer Cell, (20100000), vol. 17, pages 77 - 88
	- ENGELMAN et al., Science, (20070000), vol. 316, pages 1039 - 43
	- BEAT et al., Proc Natl Acad Sci USA, (20070000), vol. 104, pages 20932 - 7
	- Journal of Clinical Oncology, (20110000), page 7505
	- ADJEI et al., Oncologist, (20110000), vol. 16, pages 788 - 99
	- BORK; DOOLITTLE, Proc Nat Acad Sci USA, (19920000), vol. 89, pages 8990 - 8994
	- MEINKE et al., J Bacteriol, (19930000), vol. 175, pages 1910 - 1918
	- WATANABE et al., J Biol Chem, (19900000), vol. 265, pages 15659 - 15665
	- ULLRICH et al., Nature, (19840000), vol. 309, pages 418 - 425
	- "GenBank", Database accession no. NP 005219
	- "GenBank", Database accession no. NP_001120972
	- WARD et al., Nature, (19890000), vol. 341, pages 544 - 546
	- WU; KABAT, J Exp Med, (19700000), vol. 132, pages 211 - 50
	- CHOTHIA; LESK, Mol Biol, (19870000), vol. 196, pages 901 - 17
	- LEFRANC et al., Dev Comparat Immunol, (20030000), vol. 27, pages 55 - 77
	- Almagro Mol Recognit, (20040000), vol. 17, pages 132 - 43
	- AL-LAZIKANI et al., J Mol Biol, (19970000), vol. 273, pages 927 - 48
	- KNAPPIK et al., J Mol Biol, (20000000), vol. 296, pages 57 - 86
	- SHI et al., J Mol Biol, (20100000), vol. 397, pages 385 - 96
	- DOWNWARD et al., Nature, (19840000), vol. 311, pages 483 - 5
	- PANEK et al., J Pharmacol Exp Thera, (19970000), vol. 283, pages 1433 - 44
	- BATLEY et al., Life Sci, (19980000), vol. 62, pages 143 - 50
	- JACOBS et al., Protein Engineering, Design, and Selection, (20120000), vol. 25, pages 107 - 117
	- BORK; DOOLITTLE, Proc Natl Acad Sci USA, (19920000), vol. 89, pages 8990 - 8992
	- ODEGRIP et al., Proc Natl Acad Sci U S A, (20040000), vol. 101, pages 2806 - 2810
	- Current Protocols in Molecular Biology, John Wiley & Sons, Inc., (19940000), vol. 1
	- HANES; PLUCKTHUN, Proc Natl Acad Sci USA, (19970000), vol. 94, pages 4937 - 4942
	- ROBERTS; SZOSTAK, Proc Natl Acad Sci USA, (19970000), vol. 94, pages 12297 - 12302
	- LEHMANN; WYSS, Curr Opin Biotechnol, (20010000), vol. 12, pages 371 - 375
	- HALLEWELL et al., J Biol Chem, (19890000), vol. 264, pages 5260 - 5268
	- ALFTHAN et al., Protein Eng., (19950000), vol. 8, pages 725 - 731
	- ROBINSON; SAUER, Biochemistry, (19960000), vol. 35, pages 109 - 116
	- STROHL, Curr Opin Biotechnol., (20090000), vol. 20, pages 685 - 691
	- KREBS et al., J Immunol Meth, (20010000), vol. 254, pages 67 - 84
	- VAUGHAN et al., Nature Biotechnology, (19960000), vol. 14, pages 309 - 314
	- SHEETS et al., PITAS (USA, (19980000), vol. 95, pages 6157 - 6162
	- HOOGENBOOM; WINTER, J Mol Biol, (19910000), vol. 227, page 381
	- MARKS et al., J Mol Biol, (19910000), vol. 222, page 581
	- SHI et al., J. Mol. Biol., (20100000), vol. 397, pages 385 - 96
	- LI et al., Cancer Cell, (20050000), vol. 7, pages 301 - 311
	- MACLENNAN et al., Acta Physiol Scand Suppl, (19980000), vol. 643, pages 55 - 67
	- SASAKI et al., Adv Biophys, (19980000), vol. 35, pages 1 - 24
	- DALL'ACQUA et al., J Biol Chem, (20060000), vol. 281, pages 23514 - 24
	- KONNO et al., Cytotechnology, (20120000), vol. 64, pages 249 - 65
	- SHIELDS et al., J Biol Chem, (20020000), vol. 277, pages 26733 - 26740
	- OLIVIER et al., MAbs, vol. 2, no. 4, page 2010
	- SHINKAWA et al., J Biol Chem, (20030000), vol. 278, pages 3466 - 3473
	- MORI et al., Biotechnol Bioeng, (20040000), vol. 88, pages 901 - 908
	- FERRARA et al., J Biol Chem, (20060000), vol. 281, pages 5032 - 5036
	- FERRARA et al., Biotechnol Bioeng, (20060000), vol. 93, pages 851 - 861
	- XHOU et al., Biotechnol Bioeng, (20080000), vol. 99, pages 652 - 65
	- HYNES; LANE, Nature Reviews Cancer, (20050000), vol. 5, pages 341 - 354
	- SHIELDS et al., J Biol Chem, (20020000), vol. 277, pages 26733 - 40
	- NAKATA; GOTOH, Expert Opin Ther Targets, (20120000), vol. 16, pages 771 - 781
	- JANNE; JOHNSON, Clin Cancer Res, (20060000), vol. 12, no. 14, pages 4416s - 4420s
	- CAPPUZZO et al., J Natl Cancer Inst, (20050000), vol. 97, pages 643 - 55
	- VAN CUTSEM et al., N Eng J Med, (20090000), vol. 360, pages 1408 - 1417
	- LIEVRE et al., J Clin Oncol, (20080000), vol. 26, pages 374 - 379
	- AMADO et al., J Clin Oncol, (20080000), vol. 26, pages 1626 - 1634m
	- "Pharmaceutical Manufacturing", Remington: The Science and Practice of Pharmacy, Lipincott Williams and Wilkins, (20060000), pages 691 - 1092
	- Remington's Pharmaceutical Science, Mack Publishing Company
	- MAATTA et al., Mol Biol Cell, (20060000), vol. 17, pages 67 - 79
	- BIRTALAN et al., J Mol Biol, (20080000), vol. 377, pages 1518 - 28
	- OLSON et al., Protein Sci, (20070000), vol. 16, pages 476 - 84
	- CHEMICAL ABSTRACTS, Database accession no. 183321-74-6
	- CHEMICAL ABSTRACTS, Database accession no. 205923-56-4
	- FREDERICK, "NCI-Navy Medical oncology Cell Line supplement", J Cell Biochem, (19960000), vol. 24
	- TRACY S., cancer Res, (20040000), vol. 64, pages 7241 - 4
	- SHIMAMURA T., cancer Res, (20050000), vol. 65, pages 6401 - 8
	- SCALLON et al., Mol Immunol, (20070000), vol. 44, pages 1524 - 1534
	- TIMMERMAN et al., J Mol Recognition, (20070000), vol. 20, page 283
	- SLOOTSTRA et al., Molecular Diversity, (19960000), vol. 1, pages 87 - 96
	- CHEMICAL ABSTRACTS, Database accession no. 439081-18-2

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p